Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.
Journal
Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
received:
06
12
2021
accepted:
05
05
2023
medline:
13
7
2023
pubmed:
20
6
2023
entrez:
19
6
2023
Statut:
ppublish
Résumé
IgA nephropathy (IgAN) is a progressive form of kidney disease defined by glomerular deposition of IgA. Here we performed a genome-wide association study of 10,146 kidney-biopsy-diagnosed IgAN cases and 28,751 controls across 17 international cohorts. We defined 30 genome-wide significant risk loci explaining 11% of disease risk. A total of 16 loci were new, including TNFSF4/TNFSF18, REL, CD28, PF4V1, LY86, LYN, ANXA3, TNFSF8/TNFSF15, REEP3, ZMIZ1, OVOL1/RELA, ETS1, IGH, IRF8, TNFRSF13B and FCAR. The risk loci were enriched in gene orthologs causing abnormal IgA levels when genetically manipulated in mice. We also observed a positive genetic correlation between IgAN and serum IgA levels. High polygenic score for IgAN was associated with earlier onset of kidney failure. In a comprehensive functional annotation analysis of candidate causal genes, we observed convergence of biological candidates on a common set of inflammatory signaling pathways and cytokine ligand-receptor pairs, prioritizing potential new drug targets.
Identifiants
pubmed: 37337107
doi: 10.1038/s41588-023-01422-x
pii: 10.1038/s41588-023-01422-x
doi:
Substances chimiques
Immunoglobulin A
0
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1091-1105Subventions
Organisme : NIDDK NIH HHS
ID : R01 DK105124
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK082753
Pays : United States
Organisme : NIDDK NIH HHS
ID : RC2 DK116690
Pays : United States
Organisme : NLM NIH HHS
ID : R01 LM013061
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG008680
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI152960
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK078244
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI149431
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01 HG010730
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI130830
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS099068
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI024717
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR073228
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI150748
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI148276
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI150585
Pays : United States
Organisme : NIGMS NIH HHS
ID : P41 GM103311
Pays : United States
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.
Références
Feehally, J. et al. HLA has strongest association with IgA nephropathy in genome-wide analysis. J. Am. Soc. Nephrol. 21, 1791–1797 (2010).
pubmed: 20595679
pmcid: 3013538
doi: 10.1681/ASN.2010010076
Gharavi, A. G. et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat. Genet. 43, 321–327 (2011).
pubmed: 21399633
pmcid: 3412515
doi: 10.1038/ng.787
Kiryluk, K. et al. Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet. 8, e1002765 (2012).
pubmed: 22737082
pmcid: 3380840
doi: 10.1371/journal.pgen.1002765
Kiryluk, K. et al. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat. Genet. 46, 1187–1196 (2014).
pubmed: 25305756
pmcid: 4213311
doi: 10.1038/ng.3118
Yu, X. Q. et al. A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy. Nat. Genet. 44, 178–182 (2012).
doi: 10.1038/ng.1047
Li, M. et al. Identification of new susceptibility loci for IgA nephropathy in Han Chinese. Nat. Commun. 6, 7270 (2015).
pubmed: 26028593
doi: 10.1038/ncomms8270
Li, M. et al. Genome-wide meta-analysis identifies three novel susceptibility loci and reveals ethnic heterogeneity of genetic susceptibility for IgA nephropathy. J. Am. Soc. Nephrol. 31, 2949–2963 (2020).
pubmed: 32912934
pmcid: 7790208
doi: 10.1681/ASN.2019080799
Kiryluk, K., Novak, J. & Gharavi, A. G. Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies. Annu Rev. Med. 64, 339–356 (2013).
pubmed: 23072577
doi: 10.1146/annurev-med-041811-142014
Kiryluk, K. & Novak, J. The genetics and immunobiology of IgA nephropathy. J. Clin. Invest. 124, 2325–2332 (2014).
pubmed: 24892706
pmcid: 4089454
doi: 10.1172/JCI74475
Bulik-Sullivan, B. K. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
pubmed: 25642630
pmcid: 4495769
doi: 10.1038/ng.3211
Feriozzi, S. & Polci, R. The role of tonsillectomy in IgA nephropathy. J. Nephrol. 29, 13–19 (2016).
pubmed: 26582216
doi: 10.1007/s40620-015-0247-4
Liu, L. et al. Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits. Nat. Commun. 13, 6859 (2022).
pubmed: 36369178
pmcid: 9651905
doi: 10.1038/s41467-022-34456-6
de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).
pubmed: 25885710
pmcid: 4401657
doi: 10.1371/journal.pcbi.1004219
Backenroth, D. et al. FUN-LDA: a latent dirichlet allocation model for predicting tissue-specific functional effects of noncoding variation: methods and applications. Am. J. Hum. Genet. 102, 920–942 (2018).
pubmed: 29727691
pmcid: 5986983
doi: 10.1016/j.ajhg.2018.03.026
Pers, T. H. et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun. 6, 5890 (2015).
pubmed: 25597830
doi: 10.1038/ncomms6890
Iotchkova, V. et al. GARFIELD classifies disease-relevant genomic features through integration of functional annotations with association signals. Nat. Genet. 51, 343–353 (2019).
pubmed: 30692680
pmcid: 6908448
doi: 10.1038/s41588-018-0322-6
Harley, J. B. et al. Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat. Genet. 50, 699–707 (2018).
pubmed: 29662164
pmcid: 6022759
doi: 10.1038/s41588-018-0102-3
Zhou, H. et al. Epstein–Barr virus oncoprotein super-enhancers control B cell growth. Cell Host Microbe 17, 205–216 (2015).
pubmed: 25639793
pmcid: 4539236
doi: 10.1016/j.chom.2014.12.013
Sugai, M., Watanabe, K., Nambu, Y., Hayashi, T. & Shimizu, A. Functions of Runx in IgA class switch recombination. J. Cell. Biochem. 112, 409–414 (2011).
pubmed: 21268061
doi: 10.1002/jcb.22971
Malhotra, N. & Kang, J. SMAD regulatory networks construct a balanced immune system. Immunology 139, 1–10 (2013).
pubmed: 23347175
pmcid: 3634534
doi: 10.1111/imm.12076
Lage, K. et al. A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat. Biotechnol. 25, 309–316 (2007).
pubmed: 17344885
doi: 10.1038/nbt1295
Warde-Farley, D. et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 38, W214–W220 (2010).
pubmed: 20576703
pmcid: 2896186
doi: 10.1093/nar/gkq537
Han, S. S. et al. The role of TNF superfamily member 13 in the progression of IgA nephropathy. J. Am. Soc. Nephrol. 27, 3430–3439 (2016).
pubmed: 27068226
pmcid: 5084881
doi: 10.1681/ASN.2015060677
Yamada, K. et al. Leukemia inhibitory factor signaling enhances production of galactose-deficient IgA1 in IgA nephropathy. Kidney Dis. (Basel) 6, 168–180 (2020).
pubmed: 32523959
doi: 10.1159/000505748
Suzuki, H. et al. Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes. J. Biol. Chem. 289, 5330–5339 (2014).
pubmed: 24398680
doi: 10.1074/jbc.M113.512277
Yamada, K. et al. Inhibition of STAT3 signaling reduces IgA1 autoantigen production in IgA nephropathy. Kidney Int. Rep. 2, 1194–1207 (2017).
pubmed: 29270528
pmcid: 5733772
doi: 10.1016/j.ekir.2017.07.002
Vosa, U. et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat. Genet. 53, 1300–1310 (2021).
pubmed: 34475573
pmcid: 8432599
doi: 10.1038/s41588-021-00913-z
Owen, C. R., Yuan, L. & Basson, M. D. Smad3 knockout mice exhibit impaired intestinal mucosal healing. Lab. Invest. 88, 1101–1109 (2008).
pubmed: 18711354
pmcid: 3971647
doi: 10.1038/labinvest.2008.77
Yang, X. et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J. 18, 1280–1291 (1999).
pubmed: 10064594
pmcid: 1171218
doi: 10.1093/emboj/18.5.1280
Agarwal, S. et al. Human Fc receptor-like 3 inhibits regulatory T cell function and binds secretory IgA. Cell Rep. 30, 1292–1299 (2020).
pubmed: 32023449
doi: 10.1016/j.celrep.2019.12.099
Tolnay, M. Lymphocytes sense antibodies through human FCRL proteins: emerging roles in mucosal immunity. J. Leukoc. Biol. 111, 477–487 (2021).
pubmed: 33884658
doi: 10.1002/JLB.4RU0221-102RR
Choobdar, S. et al. Assessment of network module identification across complex diseases. Nat. Methods 16, 843–852 (2019).
pubmed: 31471613
pmcid: 6719725
doi: 10.1038/s41592-019-0509-5
Zhang, X. et al. An integrative investigation of the therapeutic mechanism of Ainsliaea fragrans Champ. in cervicitis using liquid chromatography tandem mass spectrometry based on a rat plasma metabolomics strategy. J. Pharm. Biomed. Anal. 156, 221–231 (2018).
pubmed: 29729635
doi: 10.1016/j.jpba.2018.04.048
Zhao, L. et al. Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-kappaB and JAK/STAT signaling pathways in rats. Int. Immunopharmacol. 48, 102–109 (2017).
pubmed: 28499193
doi: 10.1016/j.intimp.2017.05.002
Fulco, C. P. et al. Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations. Nat. Genet. 51, 1664–1669 (2019).
pubmed: 31784727
pmcid: 6886585
doi: 10.1038/s41588-019-0538-0
Fishilevich, S. et al. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database (Oxford) 2017, bax028 (2017).
pubmed: 28605766
doi: 10.1093/database/bax028
Mountjoy, E. et al. An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci. Nat. Genet. 53, 1527–1533 (2021).
pubmed: 34711957
pmcid: 7611956
doi: 10.1038/s41588-021-00945-5
Zipfel, P. F. et al. Complement inhibitors in clinical trials for glomerular diseases. Front. Immunol. 10, 2166 (2019).
pubmed: 31611870
pmcid: 6776600
doi: 10.3389/fimmu.2019.02166
Titze, S. et al. Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort. Nephrol. Dial. Transpl. 30, 441–451 (2015).
doi: 10.1093/ndt/gfu294
Wunnenburger, S. et al. Associations between genetic risk variants for kidney diseases and kidney disease etiology. Sci. Rep. 7, 13944 (2017).
pubmed: 29066732
pmcid: 5655008
doi: 10.1038/s41598-017-13356-6
Hansen, I. S., Baeten, D. L. P. & den Dunnen, J. The inflammatory function of human IgA. Cell. Mol. Life Sci. 76, 1041–1055 (2019).
pubmed: 30498997
doi: 10.1007/s00018-018-2976-8
Infante, B. et al. Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy. Clin. Kidney J. 13, 758–767 (2020).
pubmed: 33123355
pmcid: 7577761
doi: 10.1093/ckj/sfaa060
Nelson, M. R. et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 47, 856–860 (2015).
pubmed: 26121088
doi: 10.1038/ng.3314
Robertson, C. C. et al. Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes. Nat. Genet. 53, 962–971 (2021).
pubmed: 34127860
pmcid: 8273124
doi: 10.1038/s41588-021-00880-5
Fang, H. et al. A genetics-led approach defines the drug target landscape of 30 immune-related traits. Nat. Genet. 51, 1082–1091 (2019).
pubmed: 31253980
pmcid: 7124888
doi: 10.1038/s41588-019-0456-1
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).
pubmed: 25722852
pmcid: 4342193
doi: 10.1186/s13742-015-0047-8
Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
pubmed: 20616382
pmcid: 2922887
doi: 10.1093/bioinformatics/btq340
Shi, J. & Lee, S. A novel random effect model for GWAS meta-analysis and its application to trans-ethnic meta-analysis. Biometrics 72, 945–954 (2016).
pubmed: 26916671
pmcid: 4996751
doi: 10.1111/biom.12481
Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, 369–375 (2012).
pubmed: 22426310
pmcid: 3593158
doi: 10.1038/ng.2213
Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011).
pubmed: 21167468
pmcid: 3014363
doi: 10.1016/j.ajhg.2010.11.011
Jia, X. et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS ONE 8, e64683 (2013).
pubmed: 23762245
pmcid: 3675122
doi: 10.1371/journal.pone.0064683
Pillai, N. E. et al. Predicting HLA alleles from high-resolution SNP data in three Southeast Asian populations. Hum. Mol. Genet. 23, 4443–4451 (2014).
pubmed: 24698974
doi: 10.1093/hmg/ddu149
Ka, S. et al. HLAscan: genotyping of the HLA region using next-generation sequencing data. BMC Bioinformatics 18, 258 (2017).
pubmed: 28499414
pmcid: 5427585
doi: 10.1186/s12859-017-1671-3
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
pubmed: 17701901
pmcid: 1950838
doi: 10.1086/519795
Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
pubmed: 15264254
doi: 10.1002/jcc.20084
1000 Genomes Project Consortium et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56–65 (2012).
Tian, C. et al. Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections. Nat. Commun. 8, 599 (2017).
pubmed: 28928442
pmcid: 5605711
doi: 10.1038/s41467-017-00257-5
Vilhjalmsson, B. J. et al. Modeling linkage disequilibrium increases accuracy of polygenic risk scores. Am. J. Hum. Genet. 97, 576–592 (2015).
pubmed: 26430803
pmcid: 4596916
doi: 10.1016/j.ajhg.2015.09.001
Khera, A. V. et al. Polygenic prediction of weight and obesity trajectories from birth to adulthood. Cell 177, 587–596 (2019).
pubmed: 31002795
pmcid: 6661115
doi: 10.1016/j.cell.2019.03.028
Khera, A. V. et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat. Genet. 50, 1219–1224 (2018).
pubmed: 30104762
pmcid: 6128408
doi: 10.1038/s41588-018-0183-z
Gorski, M. et al. 1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function. Sci. Rep. 7, 45040 (2017).
pubmed: 28452372
pmcid: 5408227
doi: 10.1038/srep45040
Pattaro, C. et al. Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat. Commun. 7, 10023 (2016).
pubmed: 26831199
pmcid: 4735748
doi: 10.1038/ncomms10023
Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228–1235 (2015).
pubmed: 26414678
pmcid: 4626285
doi: 10.1038/ng.3404
Roadmap Epigenomics Consortium et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).
Heng, T. S. & Painter, M. W. & Immunological Genome Project Consortium. The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol. 9, 1091–1094 (2008).
Eppig, J. T. et al. The Mouse Genome Database (MGD): facilitating mouse as a model for human biology and disease. Nucleic Acids Res. 43, D726–D736 (2015).
pubmed: 25348401
doi: 10.1093/nar/gku967
Bult, C. J. et al. Mouse genome database 2016. Nucleic Acids Res. 44, D840–D847 (2016).
pubmed: 26578600
doi: 10.1093/nar/gkv1211
Hormozdiari, F., Kostem, E., Kang, E. Y., Pasaniuc, B. & Eskin, E. Identifying causal variants at loci with multiple signals of association. Genetics 198, 497–508 (2014).
pubmed: 25104515
pmcid: 4196608
doi: 10.1534/genetics.114.167908
Schmiedel, B. J. et al. Impact of genetic polymorphisms on human immune. Cell 175, 1701–1715 (2018).
pubmed: 30449622
pmcid: 6289654
doi: 10.1016/j.cell.2018.10.022
GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580–585 (2013).
Qiu, C. et al. Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease. Nat. Med. 24, 1721–1731 (2018).
pubmed: 30275566
pmcid: 6301011
doi: 10.1038/s41591-018-0194-4
Suhre, K. et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 477, 54–60 (2011).
pubmed: 21886157
doi: 10.1038/nature10354
Shin, S. Y. et al. An atlas of genetic influences on human blood metabolites. Nat. Genet. 46, 543–550 (2014).
pubmed: 24816252
pmcid: 4064254
doi: 10.1038/ng.2982
Sun, B. B. et al. Genomic atlas of the human plasma proteome. Nature 558, 73–79 (2018).
pubmed: 29875488
pmcid: 6697541
doi: 10.1038/s41586-018-0175-2
Suhre, K. et al. Connecting genetic risk to disease end points through the human blood plasma proteome. Nat. Commun. 8, 14357 (2017).
pubmed: 28240269
pmcid: 5333359
doi: 10.1038/ncomms14357
Emilsson, V. et al. Co-regulatory networks of human serum proteins link genetics to disease. Science 361, 769–773 (2018).
pubmed: 30072576
pmcid: 6190714
doi: 10.1126/science.aaq1327
Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).
pubmed: 24830394
pmcid: 4022491
doi: 10.1371/journal.pgen.1004383
Li, T. et al. A scored human protein-protein interaction network to catalyze genomic interpretation. Nat. Methods 14, 61–64 (2017).
pubmed: 27892958
doi: 10.1038/nmeth.4083
Su, G., Kuchinsky, A., Morris, J. H., States, D. J. & Meng, F. GLay: community structure analysis of biological networks. Bioinformatics 26, 3135–3137 (2010).
pubmed: 21123224
pmcid: 2995124
doi: 10.1093/bioinformatics/btq596
Nepusz, T., Yu, H. & Paccanaro, A. Detecting overlapping protein complexes in protein-protein interaction networks. Nat. Methods 9, 471–472 (2012).
pubmed: 22426491
pmcid: 3543700
doi: 10.1038/nmeth.1938
Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607–D613 (2019).
pubmed: 30476243
doi: 10.1093/nar/gky1131
Chen, J., Bardes, E. E., Aronow, B. J. & Jegga, A. G. ToppGene suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 37, W305–W311 (2009).
pubmed: 19465376
pmcid: 2703978
doi: 10.1093/nar/gkp427
Graeber, T. G. & Eisenberg, D. Bioinformatic identification of potential autocrine signaling loops in cancers from gene expression profiles. Nat. Genet. 29, 295–300 (2001).
pubmed: 11685206
doi: 10.1038/ng755
Knox, C. et al. DrugBank 3.0: a comprehensive resource for ‘omics’ research on drugs. Nucleic Acids Res. 39, D1035–D1041 (2011).
pubmed: 21059682
doi: 10.1093/nar/gkq1126
Zhu, F. et al. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 40, D1128–D1136 (2012).
pubmed: 21948793
doi: 10.1093/nar/gkr797
Carvalho-Silva, D. et al. Open targets platform: new developments and updates two years on. Nucleic Acids Res. 47, D1056–D1065 (2019).
pubmed: 30462303
doi: 10.1093/nar/gky1133
Ochoa, D. et al. Open targets platform: supporting systematic drug-target identification and prioritisation. Nucleic Acids Res. 49, D1302–D1310 (2021).
pubmed: 33196847
doi: 10.1093/nar/gkaa1027
Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604–612 (2009).
pubmed: 19414839
pmcid: 2763564
doi: 10.7326/0003-4819-150-9-200905050-00006
Schwartz, G. J. et al. New equations to estimate GFR in children with CKD. J. Am. Soc. Nephrol. 20, 629–637 (2009).
pubmed: 19158356
pmcid: 2653687
doi: 10.1681/ASN.2008030287
Stanaway, I. B. et al. The eMERGE genotype set of 83,717 subjects imputed to ~40 million variants genome wide and association with the herpes zoster medical record phenotype. Genet. Epidemiol. 43, 63–81 (2019).
pubmed: 30298529
Khan, A. et al. Medical records-based genetic studies of the complement system. J. Am. Soc. Nephrol. 32, 2031–2047 (2021).
pubmed: 33941608
pmcid: 8455263
doi: 10.1681/ASN.2020091371
Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
pubmed: 30305743
pmcid: 6786975
doi: 10.1038/s41586-018-0579-z
Denny, J. C. et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics 26, 1205–1210 (2010).
pubmed: 20335276
pmcid: 2859132
doi: 10.1093/bioinformatics/btq126